In addition, AMD3100 has been used as a chemical tool to demonstrate that small molecule antagonism of CXCR4 is a promising strategy for the treatment of different cancers, such as breast cancer [9], prostate cancer [10], and ovarian cancer [11]. The gene discussed is CXCR4; the disease is cancer.